Medication info

Ranumus Tablets

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tabletTripotassium Bismuth Dicitrate›200mg / 1 tabletSucralfate Hydrate›600mg / 1 tablet
Manufacturer / importer
Dongguk Bio Pharmaceutical Co., Ltd.
Appearance
Light green, oblong film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201905309 · Approved 2019.07.25

This product's status changed to Approval withdrawn on 2024.01.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as ulcers, gastritis, and gastroesophageal reflux disease); prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
○ Adults Usually, regardless of meals, administer 1 tablet orally twice daily, in the morning and before bedtime. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily before bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 2 tablets twice daily, in the morning and before bedtime. The same dosage applies to ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and to combination therapy to prevent gastric and duodenal ulcers during long-term NSAID use. Conditions caused by NSAID use usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing time may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily before bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 1 tablet twice daily or 2 tablets once daily before bedtime. However, in patients with severe reflux esophagitis, the dosage may be increased to 2 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 1 tablet 3 times daily and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 1 tablet twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is also preferable to administer 1 tablet on the night before surgery.

Ingredients

Manufacturer
Dongguk Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers, gastritis, and gastroesophageal reflux disease); prevention of Mendelson syndrome

  • Gastric ulcer
  • duodenal ulcer
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux
  • Mendelson's syndrome
  • postoperative ulcer
  • gastric ulcer due to NSAIDs
  • duodenal ulcer due to NSAIDs
View approved original text

This medication is used for the treatment of diseases caused by excessive gastric acid secretion, such as gastric and duodenal ulcers, gastritis, and Zollinger-Ellison syndrome. It also helps alleviate the symptoms of gastroesophageal reflux and prevent Mendelson's syndrome when administered prior to anesthesia. It is effective in preventing postoperative ulcers and treating gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). This medication improves the symptoms of patients with various gastrointestinal-related diseases.

How to take

Adult dose

○ Adults Usually, regardless of meals, administer 1 tablet orally twice daily, in the morning and before bedtime. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily before bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 2 tablets twice daily, in the morning and before bedtime. The same dosage applies to ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and to combination therapy to prevent gastric and duodenal ulcers during long-term NSAID use. Conditions caused by NSAID use usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing time may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily before bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 1 tablet twice daily or 2 tablets once daily before bedtime. However, in patients with severe reflux esophagitis, the dosage may be increased to 2 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 1 tablet 3 times daily and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 1 tablet twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is also preferable to administer 1 tablet on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis. Patients who have had allergic reactions to this medication or its ingredients should avoid administration. Patients with a history of acute porphyria should not use this medication as it may exacerbate symptoms. It is considered safe not to administer this medication to patients with impaired renal function. Patients with a history of upper gastrointestinal surgeries should consult healthcare professionals before taking this medication. It is advisable for pregnant women or women who may become pregnant to avoid taking this medication. It is preferable not to use this medication in premature infants or newborns as its safety has not been established. Patients on potassium-restricted diets need to exercise caution when taking this medication. Patients with impaired liver function or a history of drug allergies should use this medication carefully. Elderly patients or those with a history of renal dysfunction should be closely monitored when using this medication. Patients taking NSAIDs together may be at risk for gastrointestinal bleeding and require periodic testing. This medication may mask symptoms of gastric cancer; thus, patients with gastric ulcers or those experiencing newly developed dyspepsia symptoms who are middle-aged or older should confirm the absence of malignancy before taking it. Patients with Helicobacter pylori infection and gastric or duodenal ulcers should undergo bacterial eradication therapy concurrently. Patients who are severely ill, have hypophosphatemia, or are experiencing dysphagia may experience complications when using this medication and should exercise caution. Allergic reactions such as anaphylactic shock, skin rashes, and angioedema may occur while on this medication; if any symptoms arise, discontinue use immediately and inform healthcare professionals. If blood tests reveal leukopenia, thrombocytopenia, or abnormalities, discontinue this medication immediately. If liver dysfunction or jaundice symptoms occur, stop taking the medication and consult a healthcare professional. Cardiovascular side effects, such as arrhythmia or vasculitis, may rarely occur; therefore, patients should be monitored closely. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain, and stool color may change, although this typically is not a concern. Neuropsychiatric symptoms may include dizziness, drowsiness, confusion, headache, insomnia, and if any unusual symptoms arise, notify healthcare professionals. Muscle pain, joint pain, or, rarely, severe muscle damage symptoms may occur; if any symptoms arise, immediate discontinuation of the drug is required. Skin reactions such as rashes, hair loss, and itching may occur. Long-term use is not recommended; if therapeutic effects are absent, a switch to a different medication should be considered. Elderly patients or those with chronic conditions may have an increased risk of developing pneumonia and should be exercised caution. If dizziness or drowsiness occurs after taking this medication, avoid driving or operating dangerous machinery. This medication may interact with other drugs, so if any other medications are being taken, healthcare professionals should be informed. Pregnant or breastfeeding women should not take this medication for safety. Safety in children has not been established, and it is advisable not to use it in this population. In case of overdose, emergency measures such as vomiting or gastric lavage may be necessary, and in severe cases, hemodialysis may be required. This medication may reduce gastric acid secretion, potentially increasing bacterial growth in the gastrointestinal tract; therefore, ophthalmologic examinations may be necessary if used long-term.

Side effects

  • Anaphylactic shock
  • skin rash
  • hives
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 57 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulocytosis
  • pancytopenia
  • myelodysplasia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • seizures
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • malaise
  • anxiety
  • psychosis
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • myoclonic jerks
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • alopecia
  • stomatitis
  • itchy skin
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Light green, oblong film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.